The-48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased A beta load in brain

J C Lambert, D M A Mann, J M Harris, M C Chartier-Harlin, A Cumming, J Coates, H Lemmon, D StClair, T Iwatsubo, C Lendon

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Mutations in the presenilin 1 gene (PS1) account for the majority of early onset, familial, autosomal dominant forms of Alzheimer's disease (AD), whereas its role in other late onset forms of AD remains unclear. A -48 CIT polymorphism in the PS1 promoter has been associated with an increased genetic risk in early onset complex AD and moreover has been shown to influence the expression of the PS1 gene. This raises the possibility that previous conflicting findings from association studies with homozygosity for the PS1 intron 8 polymorphism might be the result of linkage disequilibrium with the -48 CC genotype. Here we provide further evidence of increased risk of AD associated with homozygosity for the -48 CC genotype (odds ratio=1.6). We also report a phenotypic correlation with A beta (40), A beta (42(43)), and total A beta load in AD brains. The -48 CC genotype was associated with 47% greater total A beta load (p <0.003) compared to CT + TT genotype bearers. These results suggest that the -48 C/T polymorphism in the PS1promoter may increase the risk of AD, perhaps by altering PS1 gene expression and thereby influencing A beta load.

Original languageEnglish
Pages (from-to)353-355
Number of pages3
JournalJournal of Medical Genetics
Volume38
Publication statusPublished - 2001

Keywords

  • Alzheimer
  • presenilin
  • promoter
  • polymorphism
  • REGULATORY REGION
  • INTRONIC POLYMORPHISM
  • GENETIC-VARIABILITY
  • PRECURSOR PROTEIN
  • DEFICIENCY
  • EXPRESSION
  • MUTATIONS

Cite this

Lambert, J. C., Mann, D. M. A., Harris, J. M., Chartier-Harlin, M. C., Cumming, A., Coates, J., ... Lendon, C. (2001). The-48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased A beta load in brain. Journal of Medical Genetics, 38, 353-355.

The-48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased A beta load in brain. / Lambert, J C ; Mann, D M A ; Harris, J M ; Chartier-Harlin, M C ; Cumming, A ; Coates, J ; Lemmon, H ; StClair, D ; Iwatsubo, T ; Lendon, C .

In: Journal of Medical Genetics, Vol. 38, 2001, p. 353-355.

Research output: Contribution to journalArticle

Lambert, JC, Mann, DMA, Harris, JM, Chartier-Harlin, MC, Cumming, A, Coates, J, Lemmon, H, StClair, D, Iwatsubo, T & Lendon, C 2001, 'The-48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased A beta load in brain' Journal of Medical Genetics, vol. 38, pp. 353-355.
Lambert, J C ; Mann, D M A ; Harris, J M ; Chartier-Harlin, M C ; Cumming, A ; Coates, J ; Lemmon, H ; StClair, D ; Iwatsubo, T ; Lendon, C . / The-48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased A beta load in brain. In: Journal of Medical Genetics. 2001 ; Vol. 38. pp. 353-355.
@article{ae08ff2a293644f1b531e27eb93fa096,
title = "The-48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased A beta load in brain",
abstract = "Mutations in the presenilin 1 gene (PS1) account for the majority of early onset, familial, autosomal dominant forms of Alzheimer's disease (AD), whereas its role in other late onset forms of AD remains unclear. A -48 CIT polymorphism in the PS1 promoter has been associated with an increased genetic risk in early onset complex AD and moreover has been shown to influence the expression of the PS1 gene. This raises the possibility that previous conflicting findings from association studies with homozygosity for the PS1 intron 8 polymorphism might be the result of linkage disequilibrium with the -48 CC genotype. Here we provide further evidence of increased risk of AD associated with homozygosity for the -48 CC genotype (odds ratio=1.6). We also report a phenotypic correlation with A beta (40), A beta (42(43)), and total A beta load in AD brains. The -48 CC genotype was associated with 47{\%} greater total A beta load (p <0.003) compared to CT + TT genotype bearers. These results suggest that the -48 C/T polymorphism in the PS1promoter may increase the risk of AD, perhaps by altering PS1 gene expression and thereby influencing A beta load.",
keywords = "Alzheimer, presenilin, promoter, polymorphism, REGULATORY REGION, INTRONIC POLYMORPHISM, GENETIC-VARIABILITY, PRECURSOR PROTEIN, DEFICIENCY, EXPRESSION, MUTATIONS",
author = "Lambert, {J C} and Mann, {D M A} and Harris, {J M} and Chartier-Harlin, {M C} and A Cumming and J Coates and H Lemmon and D StClair and T Iwatsubo and C Lendon",
year = "2001",
language = "English",
volume = "38",
pages = "353--355",
journal = "Journal of Medical Genetics",
issn = "0022-2593",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - The-48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased A beta load in brain

AU - Lambert, J C

AU - Mann, D M A

AU - Harris, J M

AU - Chartier-Harlin, M C

AU - Cumming, A

AU - Coates, J

AU - Lemmon, H

AU - StClair, D

AU - Iwatsubo, T

AU - Lendon, C

PY - 2001

Y1 - 2001

N2 - Mutations in the presenilin 1 gene (PS1) account for the majority of early onset, familial, autosomal dominant forms of Alzheimer's disease (AD), whereas its role in other late onset forms of AD remains unclear. A -48 CIT polymorphism in the PS1 promoter has been associated with an increased genetic risk in early onset complex AD and moreover has been shown to influence the expression of the PS1 gene. This raises the possibility that previous conflicting findings from association studies with homozygosity for the PS1 intron 8 polymorphism might be the result of linkage disequilibrium with the -48 CC genotype. Here we provide further evidence of increased risk of AD associated with homozygosity for the -48 CC genotype (odds ratio=1.6). We also report a phenotypic correlation with A beta (40), A beta (42(43)), and total A beta load in AD brains. The -48 CC genotype was associated with 47% greater total A beta load (p <0.003) compared to CT + TT genotype bearers. These results suggest that the -48 C/T polymorphism in the PS1promoter may increase the risk of AD, perhaps by altering PS1 gene expression and thereby influencing A beta load.

AB - Mutations in the presenilin 1 gene (PS1) account for the majority of early onset, familial, autosomal dominant forms of Alzheimer's disease (AD), whereas its role in other late onset forms of AD remains unclear. A -48 CIT polymorphism in the PS1 promoter has been associated with an increased genetic risk in early onset complex AD and moreover has been shown to influence the expression of the PS1 gene. This raises the possibility that previous conflicting findings from association studies with homozygosity for the PS1 intron 8 polymorphism might be the result of linkage disequilibrium with the -48 CC genotype. Here we provide further evidence of increased risk of AD associated with homozygosity for the -48 CC genotype (odds ratio=1.6). We also report a phenotypic correlation with A beta (40), A beta (42(43)), and total A beta load in AD brains. The -48 CC genotype was associated with 47% greater total A beta load (p <0.003) compared to CT + TT genotype bearers. These results suggest that the -48 C/T polymorphism in the PS1promoter may increase the risk of AD, perhaps by altering PS1 gene expression and thereby influencing A beta load.

KW - Alzheimer

KW - presenilin

KW - promoter

KW - polymorphism

KW - REGULATORY REGION

KW - INTRONIC POLYMORPHISM

KW - GENETIC-VARIABILITY

KW - PRECURSOR PROTEIN

KW - DEFICIENCY

KW - EXPRESSION

KW - MUTATIONS

M3 - Article

VL - 38

SP - 353

EP - 355

JO - Journal of Medical Genetics

JF - Journal of Medical Genetics

SN - 0022-2593

ER -